Press Release | Association for Accessible Medicines

Oregon State Capital building

Apr 22, 2021 | Rachel Schwartz

SB 764 Will Hurt Oregon's Most Vulnerable Patients

White Paper: Biosimilars in the U.S.: Reimbursement and Impacts to Uptake

Mar 25, 2021 | Rachel Schwartz

AAM Statement on IQVIA Report Examining Biosimilar Reimbursement and Adoption

Senior patient picking up medicines at a pharmacy

Mar 11, 2021 | Rachel Schwartz

AAM Statement on Avalere Medicare Part D Analysis

American flag in Washington D.C.

Feb 25, 2021 | Rachel Schwartz

AAM Statement on President Biden’s Supply Chain Executive Order

AAM board room

Feb 24, 2021 | Rachel Schwartz

AAM Announces 2021 Board of Directors

AAM Lobby

Feb 24, 2021 | Rachel Schwartz

AAM Announces 2021 Associate Members

Secure Our Meds

Feb 22, 2021 | Rachel Schwartz

AAM Outlines Policy Solutions for Sustained Patient Access to Generic and Biosimilar Medicines

Chiquita Brooks-LaSure

Feb 19, 2021 | Rachel Schwartz

AAM Statement on President Biden’s Nomination of Chiquita Brooks-LaSure as CMS Administrator

Potential Savings from Accelerating US Approval of Complex Generics

Feb 9, 2021 | Rachel Schwartz

Complex Generics Could Save the U.S. Health Care System Approximately $1.3 Billion Per Year

USA flag with generic medicines

Jan 21, 2021 | Rachel Schwartz

AAM Statement on Biden’s Executive Orders to Strengthen America’s COVID Response

Friendly pharmacist hands a paper bag to young female customer at the checkout counter

Jan 15, 2021 | Rachel Schwartz

AAM and Biosimilars Council Statement on CMS Decision to Update Part D Program

Katherine Tai

Dec 10, 2020 | Rachel Schwartz

AAM Statement on President-elect Biden Naming Katherine Tai as U.S. Trade Representative